Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04106388 · ClinicalTrials.gov registry record · NA
Virtual Behavioral Health Integration
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 5,777
- Enrollment target
NCT04106388: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT04106388 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 5,777 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (312% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04106388, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,777 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the effectiveness of the virtual behavioral health integration (VBHI) program compared to usual care, on reducing the total cost of care reimbursed from Medicare and value-based contracts within 90 days of a patient's primary care visit.
Primary Outcome
Total cost of care reimbursed from Medicare and value-based contracts
Interventions
- BEHAVIORAL Virtual Behavioral Health Integration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,777 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2021-05-08 |
| Phase | NA |
What the finished NCT04106388 record still lists
NCT04106388 is an interventional study that assigns participants to a tested intervention. Its 5,777 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (312% higher).
The record links to 0 conditions, and to 1 intervention - of which Virtual Behavioral Health Integration is the first listed.
NCT04106388 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04106388 about?
NCT04106388 is a clinical study titled "Virtual Behavioral Health Integration". The primary objective is to evaluate the effectiveness of the virtual behavioral health integration (VBHI) program compared to usual care, on reducing the total cost of care reimbursed from Medicare and value-based contracts within 90 days of a patient's primary care visit.
What is the current status of trial NCT04106388?
This trial is currently completed. It is a NA study. The enrollment target is 5,777 participants. The study started on 2019-08-14. Estimated completion is 2021-05-08.
What interventions are being tested in trial NCT04106388?
The interventions under investigation include: Virtual Behavioral Health Integration (BEHAVIORAL).
Who is sponsoring clinical trial NCT04106388?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04106388's enrollment target sits among peer trials
5,777 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT03959085 · 5,951 participants · Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- NCT05636176 · 5,600 participants · Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI